Impact BioMedical
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $18 | $7 | $0 | $0 |
Gross Profit | 17 | -4 | -283 | -279 |
EBITDA | -925 | -13,804 | -724 | -26,551 |
EBIT | -1,213 | -14,092 | -1,007 | -26,830 |
Net Income | -1,470 | -14,346 | -1,267 | -27,108 |
Net Change In Cash | 18 | 7 | 0 | 0 |
Free Cash Flow | -613 | -694 | -1,806 | |
Cash | 12 | 624 | 1,318 | 1,999 |
Basic Shares | 12,185 | 12,185 | 12,062 | 11,509 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $2,331 | $1,029 | $50 | $50 |
Gross Profit | 2,331 | 1,029 | 50 | |
EBITDA | -1,539 | -2,843 | -6,301 | -3,763 |
EBIT | -1,882 | -3,963 | -7,414 | -3,833 |
Net Income | -2,051 | -4,336 | -7,051 | -3,867 |
Net Change In Cash | 2,331 | 1,029 | 50 | 50 |
Free Cash Flow | -5,635 | -2,869 | -4,428 | -3,249 |
Cash | 1,999 | 1 | 2 | 142 |
Basic Shares | 41,754 | 191,298 | 11,497 | 125,189 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.12 |
2025-06-30 | -$1.18 |
2025-03-31 | -$0.11 |
2024-12-31 | -$2.36 |
